Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

The evolving science of detection of 'blood doping'.

Lundby C, Robach P, Saltin B.

Br J Pharmacol. 2012 Mar;165(5):1306-15. doi: 10.1111/j.1476-5381.2011.01822.x. Review.

2.

Anti-doping analysis and the Olympics.

Schamasch P, Rabin O.

Bioanalysis. 2012 Jul;4(13):1529-30. doi: 10.4155/bio.12.144. No abstract available.

3.

The Athlete Biological Passport: an integral element of innovative strategies in antidoping.

Vernec AR.

Br J Sports Med. 2014 May;48(10):817-9. doi: 10.1136/bjsports-2014-093560. Epub 2014 Mar 21.

PMID:
24659508
4.

Current markers of the Athlete Blood Passport do not flag microdose EPO doping.

Ashenden M, Gough CE, Garnham A, Gore CJ, Sharpe K.

Eur J Appl Physiol. 2011 Sep;111(9):2307-14. doi: 10.1007/s00421-011-1867-6. Epub 2011 Feb 20.

PMID:
21336951
5.

Detection methods for autologous blood doping.

Segura J, Monfort N, Ventura R.

Drug Test Anal. 2012 Nov;4(11):876-81. doi: 10.1002/dta.405. Epub 2012 Mar 9. Review.

PMID:
22407819
6.

Biomarker monitoring in sports doping control.

Pottgiesser T, Schumacher YO.

Bioanalysis. 2012 Jun;4(10):1245-53. doi: 10.4155/bio.12.101. Review.

PMID:
22651568
7.

Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.

Schumacher YO, Saugy M, Pottgiesser T, Robinson N.

Drug Test Anal. 2012 Nov;4(11):846-53. doi: 10.1002/dta.406. Epub 2012 Feb 28. Review.

PMID:
22374784
8.

Detection of autologous blood transfusions in athletes: a historical perspective.

Mørkeberg J.

Transfus Med Rev. 2012 Jul;26(3):199-208. doi: 10.1016/j.tmrv.2011.09.007. Epub 2011 Nov 25. Review.

PMID:
22119492
9.

OMICS-strategies and methods in the fight against doping.

Reichel C.

Forensic Sci Int. 2011 Dec 10;213(1-3):20-34. doi: 10.1016/j.forsciint.2011.07.031. Epub 2011 Aug 20.

PMID:
21862249
10.

Erythropoietin and blood doping.

Robinson N, Giraud S, Saudan C, Baume N, Avois L, Mangin P, Saugy M.

Br J Sports Med. 2006 Jul;40 Suppl 1:i30-4.

11.

Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.

Georgakopoulos C, Saugy M, Giraud S, Robinson N, Alsayrafi M.

Bioanalysis. 2012 Jul;4(13):1549-63. doi: 10.4155/bio.12.148. Review.

PMID:
22831472
12.

Gene doping in sports.

Unal M, Ozer Unal D.

Sports Med. 2004;34(6):357-62. Review.

PMID:
15157120
13.

Implementation of the biological passport: the experience of the International Cycling Union.

Zorzoli M, Rossi F.

Drug Test Anal. 2010 Nov-Dec;2(11-12):542-7. doi: 10.1002/dta.173. Epub 2010 Dec 20.

PMID:
21204287
14.
15.

Current limitations in analytical strategies.

Howman D.

Bioanalysis. 2012 Jul;4(13):1535-6. doi: 10.4155/bio.12.122. No abstract available.

PMID:
22831468
16.

Challenges and perspectives in anti-doping testing.

Schamasch P, Rabin O.

Bioanalysis. 2012 Jul;4(13):1691-701. doi: 10.4155/bio.12.145.

PMID:
22831484
17.

Treating the elite athlete: anti-doping information for the health professional.

Tandon S, Bowers LD, Fedoruk MN.

Mo Med. 2015 Mar-Apr;112(2):122-8. Review.

PMID:
25958657
18.
19.

Detecting doping use: more than an analytical problem.

Delanghe JR, Maenhout TM, Speeckaert MM, De Buyzere ML.

Acta Clin Belg. 2014 Jan-Feb;69(1):25-9. doi: 10.1179/0001551213Z.0000000009.

PMID:
24635395
20.

[Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].

Dièye AM, Diallo B, Fall A, Ndiaye M, Cissè F, Faye B.

Sante. 2005 Jul-Sep;15(3):167-70. French.

Supplemental Content

Support Center